Immunohistochemical localization of Mcl-1 and bcl-2 proteins in thymic epithelial tumours

Histopathology

Volumn 29, Issue 6, 1996, Pages 541-547

  Chen, F F ^a   Yan, J J ^a   Chang, K C ^a   Lai, W W ^b   Chen, R M Y ^a   Jin, Y T ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NONE

Author keywords

bcl 2; Mcl 1; thymic carcinoma; thymoma

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; THYMOMA;

EID: 0030444218     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-540.x     Document Type: Article

References (18)

1. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t (14: 18) chromosome translocation. Science 1984; 226; 1097-1099.
2. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: Regulalors of cell death. Blood 1992; 80; 879-886.
3. Jiang SX, Sato Y, Kuwao S, Kameya T. Expression of Bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J. Pathol. 1995; 177; 135-138.
4. Lipponen P, Pietiläinen T, Kosma V-M, Aaltomaa S, Eskelinen M, Syrjäen K. Apoptosis suppressing protein Bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J. Pathol. 1995; 177; 49-55.
5. Pezzella F, Turley H, Kuzu I et al. Bcl-2 protein in non-small-cell lung carcinoma. N Engl. J. Med. 1993; 329; 690-694.
6. Kozopas KM, Yang T, Buchan HI, Zhou P, Craig RW. Mcl-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl-2. Proc. Natl. Acad. Sci. USA 1993; 90; 3516-3520.
7. Reynolds JE, Yang T, Qian L et al. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res. 1994; 54; 6348-6352.
8. Sato T, Hanada M, Bodrug S et al. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. U.S.A. 1994; 91; 9238-9242.
9. Lmo J, Smeland EB, Krajewski S, Reed JC, Blomhof HK. Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res. 1996; 56; 40-43.
10. Krajewski S, Bodrug S, Krajewska M et al. Immunohistochemical analysis of Mcl-1 protein in human tissues: Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am. J. Pathol. 1995; 146; 1309-1319.
11. Yang T, Kozopas KM, Craig RW. The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. Cell. Biol. 1995; 128; 1173-1184.
12. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am. J. Pathol. 1994; 145; 515-525.
13. Rosai J, Levine FD. Tumours of the thymus. In Atlas of tumour pathology. Second series, fascicle 13. Washington DC: Armed Forces Institute of Pathology, 1976; 34-161.
14. Marino M, Müller-Hermelink HK. Thymoma and thymic carcinoma: Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch. A 1985; 407; 119-149.
15. Suster S; Rosai J. Thymic carcinoma: A clinicopathologic study of 60 cases. Cancer 1991; 67; 1025-1032.
16. Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Müller-Hermelink HK. Well-differentiated thymic carcinoma: An organotypical low-grade carcinoma with relationship to cortical thymoma. Virchows Arch. A 1992; 16; 1153-1169.
17. Kornstein MJ. Tumours of the thymic epithelial cell. In Pathology of the thymus and mediastinum. Major problems in pathology series. Vol. 33. Philadelphia: WB Saunders, 1995; 67-113.
18. Pescarmona E, Rosati S, Rendina EA, Venuta F, Baroni CD. Well-differentiated thymic carcinoma: A clinico-pathological study. Virchows Arch. A 1992; 420; 179-183.